C Menendez-Botet
About
In The Last Decade
C Menendez-Botet
10 papers receiving 493 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 158
- Genetics 119
- Pulmonary and Respiratory Medicine 103
- Nutrition and Dietetics 98
- Oncology 88
Countries citing papers authored by C Menendez-Botet
This map shows the geographic impact of C Menendez-Botet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Menendez-Botet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Menendez-Botet more than expected).
Fields of papers citing papers by C Menendez-Botet
This network shows the impact of papers produced by C Menendez-Botet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Menendez-Botet. The network helps show where C Menendez-Botet may publish in the future.
Co-authorship network of co-authors of C Menendez-Botet
This figure shows the co-authorship network connecting the top 25 collaborators of C Menendez-Botet. A scholar is included among the top collaborators of C Menendez-Botet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Menendez-Botet. C Menendez-Botet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. | 96 |
| 2 | Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. | 37 |
| 3 | 89 | |
| 4 | 31 | |
| 5 | 43 | |
| 6 | 116 | |
| 7 | 4 | |
| 8 | Barr body distribution and estrogen receptor protein in mammary carcinoma. | 15 |
| 9 | 58 | |
| 10 | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.